Advertisement
Screener

LIMINAL BIOSCIENCES INC. Expense From Share-based Payment Transactions With Employees

LIMINAL BIOSCIENCES INC. Expense From Share-based Payment Transactions With Employees

LIMINAL BIOSCIENCES INC. reported Expense From Share-based Payment Transactions With Employees of CAD 243.00 thousand for the 3-month period ending 2023-06-30, per its 6-K filed 2023-08-08.

Discontinued › Expense Statement › Operating Expenses

ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees · last filed 2023-08-08

  • LIMINAL BIOSCIENCES INC. expense from share-based payment transactions with employees for the quarter ending 2023-06-30 was 243.00K CAD, a 54.75% decline year-over-year.
  • LIMINAL BIOSCIENCES INC. expense from share-based payment transactions with employees for the quarter ending 2022-06-30 was 537.00K CAD, a 43.89% decline year-over-year.
  • LIMINAL BIOSCIENCES INC. expense from share-based payment transactions with employees for the quarter ending 2021-06-30 was 957.00K CAD, a 60.52% decline year-over-year.
  • LIMINAL BIOSCIENCES INC. expense from share-based payment transactions with employees for the quarter ending 2020-06-30 was 2.42M CAD, a 83.73% decline year-over-year.
Period endExpense From Share-based Payment Transactions With Employees 3 monthExpense From Share-based Payment Transactions With Employees 6 monthExpense From Share-based Payment Transactions With Employees 12 month
2023-06-30243.00K CAD
6-K · filed 2023-08-08
530.00K CAD
6-K · filed 2023-08-08
2022-12-311.86M CAD
20-F · filed 2023-03-15
2022-06-30537.00K CAD
6-K · filed 2023-08-08
1.16M CAD
6-K · filed 2023-08-08
2021-12-314.25M CAD
20-F · filed 2023-03-15
2021-06-30957.00K CAD
6-K · filed 2022-08-10
1.87M CAD
6-K · filed 2022-08-10
2020-12-316.23M CAD
20-F · filed 2023-03-15
2020-06-302.42M CAD
6-K · filed 2021-08-16
4.80M CAD
6-K · filed 2021-08-16
2019-12-3122.03M CAD
20-F · filed 2022-03-18
2019-06-3014.90M CAD
6-K · filed 2020-08-10
16.43M CAD
6-K · filed 2020-08-10
2018-12-316.72M CAD
20-F · filed 2021-03-24
2017-12-318.66M CAD
20-F · filed 2020-03-20